We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Chemizon and CrystalGenomics Announce Collaboration

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Chemizon and CrystalGenomics Announce Collaboration"

First Name*
Last Name*
Email Address*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:

Chemizon Inc. has announced that CrystalGenomics (CG) has chosen Chemizon as its process chemistry partner to reengineer certain early stage routes, making them conducive for scale up.

As part of this program, Chemizon’s scientists will develop and optimize new synthetic routes that are designed to reduce CG’s overall manufacturing costs and accelerate their development timelines.

“As CrystalGenomics continues its rapid growth, we regularly seek to identify reliable partners whose core competencies augment our internal capabilities. We were impressed by Chemizon’s process chemistry team and their technical capabilities. In addition, Chemizon’s proposal provided the best combination of scientific merit and financial creativity. We look forward to a successful partnership,” said Seonggu Ro, Ph.D., Vice President and CTO of CrystalGenomics.

“We are very pleased that CrystalGenomics chose Chemizon to execute this research program. Chemizon has assembled an outstanding scientific team and continues to build a world-class research organization with expertise in drug discovery and process research. This agreement with a top-tier life science company like CrystalGenomics, validates our efforts,” said Anthony Piscopio, Ph.D., Chairman and CEO of Chemizon Inc.